Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Czechia

Research and Innovation Action · Running

2D-BioPAD Supple Graphene Bio-Platform for point-of-care early detection and monitoring of Alzheimer’s Disease

Coordinator
Univerzita Palackeho V Olomouci, Czechia
Runs
1 October 2023 to 30 September 2027
Status
Running
EU funding
€6.0m
Total cost
€6.0m
Partners
11 organisations in 8 countries
Type
Research and Innovation Action
Grant agreement
101120706

What the project is doing

In the project's own words, from its summary on CORDIS.

2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Alzheimer's Disease, with special focus on earlier stages such as Subjective or Mild Cognitive Impairment (SCI/MCI).

Who is involved

OrganisationCityCountryRole
Univerzita Palackeho V OlomouciOlomoucCzechiaCoordinator
Zentralinstitut Fuer Seelische GesundheitMannheimGermanyParticipant
Evnia ApsAarhus CDenmarkParticipant
Aristotelio Panepistimio ThessalonikisThessalonikiGreeceParticipant
Elliniki Etairia Nosoy Alzheimer Kai Syggenon Diatarachon SomateioThessalonikiGreeceParticipant
Q-Plan International Advisors PcKalamaria, ThessalonikiGreeceParticipant
Fundacio Institut Catala De Nanociencia I NanotecnologiaBellaterra (Barcelona)SpainParticipant
Ita-Suomen YliopistoKuopioFinlandParticipant
GraphealLa TroncheFranceParticipant
NovaptechGradignanFranceParticipant
University College Dublin, National University of Ireland, DublinDublinIrelandParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI